feed,title,long_url,short_url
InsiderMonkey,"Bernstein Raises Coinbase (COIN) PT, Maintains Outperform Rating",https://insidermonkey.com/blog/--1563843,
InsiderMonkey,"Mizuho Lowers Fiserv (FI) Price Target, Keeps Outperform Rating",https://insidermonkey.com/blog/--1563845,
InsiderMonkey,"Compass Point Lifts Robinhood (HOOD) PT, Keeps Buy Rating",https://insidermonkey.com/blog/--1563847,
InsiderMonkey,"Jefferies Raises Block (XYZ) Price Target, Keeps Buy Rating",https://insidermonkey.com/blog/--1563849,
InsiderMonkey,Cantor Fitzgerald Reaffirms Neutral Rating on Shopify (SHOP),https://insidermonkey.com/blog/--1563851,
InsiderMonkey,"JPMorgan Raises PT for Nu Holdings (NU), Keeps Overweight Rating",https://insidermonkey.com/blog/--1563853,
InsiderMonkey,Mizuho Keeps Outperform Rating on Intuit (INTU) After AI Agents Launch,https://insidermonkey.com/blog/--1563855,
InsiderMonkey,RBC Capital Maintains Outperform Rating on PayPal (PYPL),https://insidermonkey.com/blog/--1563857,
InsiderMonkey,"UBS Raises MercadoLibre (MELI) Price Target, Keeps Buy Rating",https://insidermonkey.com/blog/--1563859,
InsiderMonkey,Barclays Keeps Overweight Rating on Mastercard (MA) Despite Stablecoin Concerns,https://insidermonkey.com/blog/--1563861,
InsiderMonkey,"Citi Stays Positive on Visa (V), Keeps Buy Rating",https://insidermonkey.com/blog/--1563863,
InsiderMonkey,"Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating",https://insidermonkey.com/blog/--1563816,
InsiderMonkey,"Craig-Hallum Reiterates a Buy Rating on Clover Health Investments (CLOV), Sets a $6 PT",https://insidermonkey.com/blog/--1563817,
InsiderMonkey,Bernstein Keeps a Buy on Agilon Health (AGL) With a Price Target of $7.50,https://insidermonkey.com/blog/--1563818,
InsiderMonkey,"Morgan Stanley Maintains a Buy Rating on LifeStance Health (LFST), Keeps the PT at $10",https://insidermonkey.com/blog/--1563819,
InsiderMonkey,Compass Point Remains Bullish on DeFi Technologies (DEFT),https://insidermonkey.com/blog/--1563820,
InsiderMonkey,Craig-Hallum Keeps a Buy Rating on Stagwell Inc. (STGW),https://insidermonkey.com/blog/--1563821,
InsiderMonkey,Leerink Partners Reiterates a Buy Rating on Akebia Therapeutics (AKBA) With a $7 PT,https://insidermonkey.com/blog/--1563822,
InsiderMonkey,Jefferies Maintains a Buy on Kosmos Energy (KOS),https://insidermonkey.com/blog/--1563823,
InsiderMonkey,"H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3",https://insidermonkey.com/blog/--1563824,
